Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems
Frontiers in Pharmacology · 03.03.2025 · 16
DOI: 10.3389/fphar.2025.1534798 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.03.2025. Verfasst von Min Jin und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Formononetin (FMN) is a common natural metabolite that can be extracted and isolated from some common botanical drugs. In recent years, FMN has garnered increasing attention due to its beneficial biological activities. In this paper, we systematically summarize the sources of FMN and provide a comprehensive review of its pharmacological activities and molecular mechanisms, co-administration, toxicity, derivatives, and drug delivery systems in the last 5 years. The study results found that FMN has a wide range of pharmacological activities in neurological disorders, organ damage and cancer, showing great potential for clinical application and broad prospects. Researchers are exploring various types of delivery systems, including nanoparticle carriers, ligand modifications and polymer microspheres. These advanced delivery systems can enhance the stability of FMN, prolong its release time in vivo , and improve targeting, thereby optimizing its therapeutic efficacy and reducing side effects, and greatly improving its bioavailability. In conclusion, FMN is a natural metabolite with considerable research value, and its diverse biological activities make it a promising candidate for drug development and medical research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Thyroid and Breast Surgery, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Weifang Hospital of Traditional Chinese Medicine, Weifang, China.
- Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zitieren
APA
Jin, M., Wei, L., Wang, J., Shen, Y., Gao, L., Zhao, F., Gao, Q., Ma, Y., Sun, Y., Lin, Y., Ji, G., Cai, P., & Yan, R. (2025). Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1534798
Vancouver
Jin M, Wei L, Wang J, Shen Y, Gao L, Zhao F, et al. Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1534798
BibTeX
@article{Jin2025,
author = {Jin, Min and Wei, Linfang and Wang, Jianhua and Shen, Yuehong and Gao, Lei and Zhao, Fan and Gao, Qianying and Ma, Yifei and Sun, Yongyan and Lin, Ying and Ji, Guanjie and Cai, Pingping and Yan, Rugen},
title = {Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1534798}
}
EUVIMED